Clearance of the Rodent Retrovirus, XMuLV, by Protein A Chromatography

被引:16
作者
Bach, Julia [1 ]
Connell-Crowley, Lisa [1 ]
机构
[1] Amgen Inc, Drug Subst Dev, Seattle, WA 98119 USA
关键词
protein A chromatography; XMuLV; virus clearance; monoclonal antibody; QPCR; wash development; HOST-CELL PROTEINS; MONOCLONAL-ANTIBODIES; VIRUS REMOVAL; EXCHANGE CHROMATOGRAPHY; PURIFICATION PROCESS; VIRAL CLEARANCE; IDENTIFICATION;
D O I
10.1002/bit.25484
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Protein A chromatography is the most common unit operation used in the manufacture of therapeutic monoclonal antibodies (mAbs) due to its high affinity and specificity for the IgG Fc domain. However, protein A chromatography is often not effective for viral clearance. Typical log reduction values (LRV) for the model retrovirus XMuLV range between 1 and 4 logs, while effective steps such as viral filtration can achieve 5-7 logs of clearance. XMuLV LRVs obtained on protein A are reproducible for a given mAb, but can vary widely for different mAbs, even with the same operating conditions. In order to understand the mechanism of XMuLV clearance on protein A, we have investigated its partitioning on Mabselect SuRe protein A resin and explored how the virus interacts with resin, product, and impurities. The results show that XMuLV has some interaction with the resin backbone and ligand, but also appears to bind to and coelute with the mAb. The interaction with product was further examined by evaluating the effect of feed conditions, loading, and different washes on XMuLV partitioning on the column. Understanding the mechanism of XMuLV removal on a protein A, resin provides insight into the variability and low viral clearance of this step and suggests ways in which the removal of virus by this step can be improved. Biotechnol. Bioeng. 2015;112: 743-750. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:743 / 750
页数:8
相关论文
共 34 条
  • [1] ENDOGENOUS ORIGIN OF DEFECTIVE RETROVIRUS-LIKE PARTICLES FROM A RECOMBINANT CHINESE-HAMSTER OVARY CELL-LINE
    ANDERSON, KP
    LOW, MAL
    LIE, YS
    KELLER, GA
    DINOWITZ, M
    [J]. VIROLOGY, 1991, 181 (01) : 305 - 311
  • [2] ANDERSON KP, 1991, DEV BIOLOGICALS, V75, P123
  • [3] [Anonymous], PROCESS SCALE BIOSEP
  • [4] Brorson K, 2004, DEV BIOLOGICALS, V118, P17
  • [5] Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-use
    Brorson, K
    Brown, J
    Hamilton, E
    Stein, KE
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2003, 989 (01) : 155 - 163
  • [6] Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins
    Brorson, K
    Sherrie, K
    Lee, K
    Hamilton, E
    Stein, K
    Xu, Y
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2003, 82 (03) : 321 - 329
  • [7] Impact of cell culture process changes on endogenous retrovirus expression
    Brorson, K
    de Wit, C
    Hamilton, E
    Mustafa, M
    Swann, PG
    Kiss, R
    Taticek, R
    Polastri, G
    Stein, KE
    Xu, Y
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2002, 80 (03) : 257 - 267
  • [8] Chen D, 2012, PDA FDA VIR TSE SAF
  • [9] Using high throughput screening to define virus clearance by chromatography resins
    Connell-Crowley, Lisa
    Larimore, Elizabeth A.
    Gillespie, Ron
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2013, 110 (07) : 1984 - 1994
  • [10] Cation exchange chromatography provides effective retrovirus clearance for antibody purification processes
    Connell-Crowley, Lisa
    Thao Nguyen
    Bach, Julia
    Chinniah, Shivanthi
    Bashiri, Houman
    Gillespie, Ron
    Moscariello, John
    Hinckley, Peter
    Dehghani, Houman
    Vunnum, Suresh
    Vedantham, Ganesh
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2012, 109 (01) : 157 - 165